Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Article in Expert Review of Clinical Pharmacology (May 2023)
The most recent citing publications are shown below. View all 103 publications that cite this research output on Dimensions.
Article in Expert Review of Clinical Pharmacology (May 2023)
Article in American Journal of Therapeutics (April 2023)
Article in Immunological Reviews (November 2022)